bioRxivBioinformaticsPreprint
The target landscape of N4-hydroxycytidine based on its chemical neighborhood
Abstract
N4-hydroxycytidine (NHC) has been recently reported to have promising antiviral activity against SARS-CoV-2. To join worldwide efforts in identifying potential drug targets against this pandemic, the target landscape of NHC was defined by extracting all known targets of its chemical neighborhood, including drugs, analogues, and metabolites, and by performing target predictions from two independent platforms, following the recent Public Health Assessment via Structural Evaluation (PHASE) protocol. The analysis provides a list of over 30 protein targets that could be useful in future design activities of new COVID-19 antivirals. The relevance for existing drugs within the same chemical space, such as remdesivir, is also discussed.
- Citations
- 5
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis of anti-SARS-CoV-2 activity of HCQ: specific binding to N protein to disrupt its interaction with nucleic acids and LLPS
- N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replication
Kim M. Stegmann, Antje Dickmanns, … Matthias Dobbelstein·bioRxiv·Jun 28, 2021
- Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp13 Helicase
R. Beale, A. P. Bertolin, … J. Zeng·bioRxiv·Apr 7, 2021
- A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease.
J. D. Baker, R. L. Uhrich, … B. C. Kraemer·PLOS ONEPeer-reviewed·Feb 1, 2021
- Repurposing screen highlights broad-spectrum coronavirus antivirals and their host targets
S. Haid, A. Matthaei, … T. Pietschmann·bioRxiv·Jul 14, 2021
- Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
M. A. White, W. Lin, X. Cheng·bioRxiv·Aug 9, 2020